Showing results (1-10 of 150) with videos related to
Sort By:
Pageof 15
Cells|January 10, 2025
Minichromosome Maintenance Proteins: From DNA Replication to the DNA Damage ResponseAgnes Malysa, Xiaohong Mary Zhang, Gerold BeplerAntioxidants (Basel, Switzerland)|October 27, 2022
The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19Ananda S Prasad, Agnes Malysa, Gerold Bepler, et al.Journal of Cancer Biology|November 8, 2021
Implications of the USP10-HDAC6 axis in lung cancer - A path to precision medicineXiaohong Mary Zhang, Navnath Gavande, Prahlad Parajuli, et al.Plos One|March 14, 2013
A kinome screen identifies checkpoint kinase 1 (CHK1) as a sensitizer for RRM1-dependent gemcitabine efficacyJun Zhou, Zhengming Chen, Agnes Malysa, et al.Journal of Cellular Physiology|June 29, 2018
RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancerMay Chammaa, Agnes Malysa, Carlos Redondo, et al.Journal of Biochemistry|April 24, 2023
Acetylation of MLH1 by CBP increases cellular DNA mismatch repair activityMu Zhang, Jiawei Zhao, Peter M Glazer, et al.Lung Cancer (Amsterdam, Netherlands)|November 18, 2005
Using translational research to tailor the use of chemotherapy in the treatment of NSCLCGerold BeplerLung Cancer (Amsterdam, Netherlands)|October 27, 2006
Pharmacogenomics: a reality or still a promise?Gerold BeplerCell Death & Disease|May 9, 2020
The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53Chen Hu, Mu Zhang, Niko Moses, et al.Cancer Research|July 5, 2006
Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductaseAshish Gautam, Gerold BeplerPageof 15